Sangita M. Baxi
Publications by Year
Research Areas
Lung Cancer Research Studies, PI3K/AKT/mTOR signaling in cancer, Computational Drug Discovery Methods, Biological Research and Disease Studies, Cell Adhesion Molecules Research
Most-Cited Works
- → Impact of Project ECHO Models of Medical Tele-Education: a Systematic Review(2019)186 cited
- → Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity(2012)162 cited
- → Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses(2005)118 cited
- → Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants(2016)93 cited
- → miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells(2013)93 cited
- → Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design(2012)79 cited
- → Mindfulness meditation for workplace wellness: An evidence map(2019)74 cited
- → Radiation Therapy for Brain Metastases: A Systematic Review(2021)44 cited
- → Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90(2011)34 cited
- → Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216(2013)34 cited